| Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology ME Shy, EM Frohman, YT So, JC Arezzo, DR Cornblath, MJ Giuliani, ... Neurology 60 (6), 898-904, 2003 | 686 | 2003 |
| A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis RG Miller, JH Petajan, WW Bryan, C Armon, RJ Barohn, JC Goodpasture, ... Annals of neurology 39 (2), 256-260, 1996 | 422 | 1996 |
| Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy JR Mendell, RJ Barohn, ML Freimer, JT Kissel, W King, HN Nagaraja, ... Neurology 56 (4), 445-449, 2001 | 357 | 2001 |
| Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease GJ Parry, S Clarke Muscle & Nerve: Official Journal of the American Association of …, 1988 | 350 | 1988 |
| Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial MI Weintraub, GI Wolfe, RA Barohn, SP Cole, GJ Parry, G Hayat, ... Archives of physical medicine and rehabilitation 84 (5), 736-746, 2003 | 323 | 2003 |
| Sensory neuropathy with low‐dose pyridoxine GJ Parry, DE Bredesen Neurology 35 (10), 1466-1466, 1985 | 271 | 1985 |
| Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis RG Miller, DH Moore, DF Gelinas, V Dronsky, M Mendoza, RJ Barohn, ... Neurology 56 (7), 843-848, 2001 | 260 | 2001 |
| Inflammatory neuroprithy in homosexual men with lymphadenopathy WI Lipkin, G Parry, D Kiprov, D Abrams Neurology 35 (10), 1479-1479, 1985 | 260 | 1985 |
| Electrophysiologic evaluation of lumbosacral radiculopathies: electromyography, late responses, and somatosensory evoked potentials MJ Aminoff, DS Goodin, GJ Parry, NM Barbaro, PR Weinstein, ... Neurology 35 (10), 1514-1514, 1985 | 248 | 1985 |
| Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial RR Voskuhl, HJ Wang, TCJ Wu, NL Sicotte, K Nakamura, F Kurth, N Itoh, ... The Lancet Neurology 15 (1), 35-46, 2016 | 211 | 2016 |
| Conduction block in clinical practice DR Cornblath, AJ Sumner, J Daube, RW Gilliat, WF Brown, GJ Parry, ... Muscle & Nerve: Official Journal of the American Association of …, 1991 | 199 | 1991 |
| Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis RG Miller, D Moore, LA Young, C Armon, RJ Barohn, MB Bromberg, ... Neurology 47 (6), 1383-1388, 1996 | 185 | 1996 |
| Peripheral neuropathies associated with human immunodeficiency virus infection GJ Parry Annals of Neurology: Official Journal of the American Neurological …, 1988 | 179 | 1988 |
| Quantitative sensory testing: effect of site and skin temperature on thermal thresholds LG Hagander, HA Midani, MA Kuskowski, GJG Parry Clinical neurophysiology 111 (1), 17-22, 2000 | 171 | 2000 |
| Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy CL Koski, M Baumgarten, LS Magder, RJ Barohn, J Goldstein, M Graves, ... Journal of the neurological sciences 277 (1-2), 1-8, 2009 | 166 | 2009 |
| Neuropathies associated with excessive exposure to lead RM Thomson, GJ Parry Muscle & Nerve: Official Journal of the American Association of …, 2006 | 155 | 2006 |
| Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice KC Gorson, IN Van Schaik, ISJ Merkies, RA Lewis, RJ Barohn, CL Koski, ... Journal of the Peripheral Nervous System 15 (4), 326-333, 2010 | 149 | 2010 |
| Nerve conduction studies in Charcot‐Marie‐Tooth polyneuropathy associated with a segmental duplication of chromosome 17 DA Kaku, GJ Parry, R Malamut, JR Lupski, CA Garcia Neurology 43 (9), 1806-1806, 1993 | 142 | 1993 |
| Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria MA Ross, RG Miller, L Berchert, G Parry, RJ Barohn, C Armon, WW Bryan, ... Neurology 50 (3), 768-772, 1998 | 140 | 1998 |
| Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis GJ Parry, CMP Rodrigues, MM Aranha, SJ Hilbert, C Davey, P Kelkar, ... Clinical neuropharmacology 33 (1), 17-21, 2010 | 139 | 2010 |
